arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BIO KEY INTERNATIONAL INC

BKYI
$2.44 ▼ -0.07 (-2.79%) at close
Technology ·Services-Prepackaged Software ·USServices-Prepackaged Software
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
11
Health
Poor
Bearish
auto_awesome

Analytical Summary

BIO KEY INTERNATIONAL INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.5M
Dividend Yield —
Revenue Growth 13.1% ↘
Op. Margin -27.6% ↘
ROIC -12.2% ↘
FCF / Share $-0.82 ↘
Trailing P/E —
Price / Book 0.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.92M
↑ +13.1% —
Net Income Profit after all expenses
$-205.04K
↑ +72.2% —
Operating Margin Operating profit as % of sales
-27.6%
↓ -275.1% 2th
FCF / Share Free cash flow per share
$-0.82
↓ -135.8% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
2
Returns ↓
6
Financial Health ↑
13
Cash Quality ↓
46

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters